Based on the above findings, we propose that these key genes synergistically initiate and accelerate AD by regulating glymphatic system architecture and function, modulating neuroinflammatory pathways, and altering amyloid-β and tau clearance efficiency. Here, MAPT is linked to Alzheimer disease.